Document is current
Any future updates will be listed below
-
Authors
Gozes, Illana https://orcid.org/0000-0001-9796-2430
Blatt, Jason https://orcid.org/0009-0009-3278-5782
Lobyntseva, Alexandra
- License Information
-
More Information
Article History
Received: 19 March 2024
Revised: 18 September 2024
Accepted: 23 September 2024
First Online: 2 October 2024
Competing interests
: Sex-dependent use of davunetide is under an international patent application No. PCT PCT/IL2022/051314 (IG and AL are listed as inventors). This PCT is licensed to ExoNavis Therapeutics Ltd, where IG serves as VP Drug Development. JB has nothing to disclose.
